by admin_63069 | Dec 4, 2024 | Related Topics
Johns Hopkins Medicine-led research is believed to be the first to provide evidence of this association.
by admin_63069 | Dec 2, 2024 | News You Can Use
The trial excluded patients with recent chemotherapy, immunotherapy, or major surgeries, ensuring a focused study population.
by admin_63069 | Nov 27, 2024 | Related Topics
Among patients with hormone-sensitive prostate cancer, circulating tumor cell (CTC) count at the start of treatment may be able to indicate which patients are likely to live longer after treatment, as well as those who may be good candidates for novel therapies and...
by admin_63069 | Nov 20, 2024 | Related Topics
Efficacy, trials, and combination therapies